An organic selenium compound attenuates apomorphine-induced stereotypy in mice

[1]  B. Frey,et al.  Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. , 2006, Journal of psychiatry & neuroscience : JPN.

[2]  B. Frey,et al.  Increased oxidative stress after repeated amphetamine exposure: possible relevance as a model of mania. , 2006, Bipolar disorders.

[3]  B. Frey,et al.  Changes in Antioxidant Defense Enzymes after d-amphetamine Exposure: Implications as an Animal Model of Mania , 2006, Neurochemical Research.

[4]  R. Roesler,et al.  Long-term memory for aversive training is impaired in Idua −/− mice, a genetic model of mucopolysaccharidosis type I , 2006, Brain Research.

[5]  R. Roesler,et al.  Non-associative learning and anxiety in rats treated with a single systemic administration of the gastrin-releasing peptide receptor antagonist RC-3095 , 2005, Peptides.

[6]  Jacques Corbeil,et al.  Comparative gene expression analysis of blood and brain provides concurrent validation of SELENBP1 up-regulation in schizophrenia , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Roesler,et al.  Pro-oxidant action of diphenyl diselenide in the yeast Saccharomyces cerevisiae exposed to ROS-generating conditions. , 2005, Life sciences.

[8]  R. Pessoa-Pureur,et al.  Organoselenium compounds prevent hyperphosphorylation of cytoskeletal proteins induced by the neurotoxic agent diphenyl ditelluride in cerebral cortex of young rats. , 2005, Toxicology.

[9]  A. Green,et al.  Free radical trapping as a therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers. , 2005, Current drug targets. CNS and neurological disorders.

[10]  M. Kanter,et al.  Neuroprotective Effects of Ebselen on Experimental Spinal Cord Injury in Rats , 2005, Neurochemical Research.

[11]  R. Roesler,et al.  The bombesin/gastrin releasing peptide receptor antagonist RC-3095 blocks apomorphine but not MK-801-induced stereotypy in mice , 2004, Peptides.

[12]  R. Roesler,et al.  Oxidative damage in brains of mice treated with apomorphine and its oxidized derivative , 2003, Brain Research.

[13]  D. Souza,et al.  Diphenyl diselenide protects rat hippocampal slices submitted to oxygen–glucose deprivation and diminishes inducible nitric oxide synthase immunocontent , 2003, Brain Research.

[14]  R. Roesler,et al.  An oxidized form of apomorphine fails to induce stereotypy , 2003, Schizophrenia Research.

[15]  D. Souza,et al.  Neuroprotective effect of ebselen on rat hippocampal slices submitted to oxygen–glucose deprivation: correlation with immunocontent of inducible nitric oxide synthase , 2003, Neuroscience Letters.

[16]  R. Roesler,et al.  Facilitation of long-term object recognition memory by pretraining administration of diphenyl diselenide in mice , 2003, Neuroscience Letters.

[17]  J. Rocha,et al.  Investigations into the potential neurotoxicity induced by diselenides in mice and rats. , 2003, Toxicology.

[18]  I. Izquierdo,et al.  Intrahippocampal infusion of ebselen impairs retention of an inhibitory avoidance task in rats. , 2002, European journal of pharmacology.

[19]  A. Cools,et al.  Apomorphine Susceptibility and Animal Models for Psychopathology: Genes and Environment , 2002, Behavior genetics.

[20]  H. Canatan,et al.  Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder , 2002, Cell biochemistry and function.

[21]  I. Izquierdo,et al.  Differential neurobehavioral deficits induced by apomorphine and its oxidation product, 8-oxo-apomorphine-semiquinone, in rats. , 2002, European journal of pharmacology.

[22]  J. I. Rossato,et al.  Antioxidant Properties of New Chalcogenides Against Lipid Peroxidation in Rat Brain , 2002, Neurochemical Research.

[23]  D. Souza,et al.  Diphenyl diselenide and diphenyl ditelluride affect the rat glutamatergic system in vitro and in vivo , 2001, Brain Research.

[24]  D. Souza,et al.  Ebselen prevents excitotoxicity provoked by glutamate in rat cerebellar granule neurons , 2001, Neuroscience Letters.

[25]  A. Imperato,et al.  The Antioxidant Ebselen Prevents Neurotoxicity and Clinical Symptoms in a Primate Model of Parkinson's Disease , 2000, Experimental Neurology.

[26]  I Izquierdo,et al.  Role of hippocampal signaling pathways in long-term memory formation of a nonassociative learning task in the rat. , 2000, Learning & memory.

[27]  M. Parnham,et al.  Ebselen: prospective therapy for cerebral ischaemia , 2000, Expert opinion on investigational drugs.

[28]  I. Izquierdo,et al.  Normal inhibitory avoidance learning and anxiety, but increased locomotor activity in mice devoid of PrP(C). , 1999, Brain research. Molecular brain research.

[29]  H. Kikuchi,et al.  Ebselen in Acute Middle Cerebral Artery Occlusion: A Placebo-Controlled, Double-Blind Clinical Trial , 1999, Cerebrovascular Diseases.

[30]  K. Takakura,et al.  Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage. , 1998, Neurosurgery.

[31]  G. Zeni,et al.  Stereospecific Formation of Chalcogenoenynes via Palladium Catalysed Cross-Coupling Reaction of α-Bromovinylic Chalcogenides , 1998 .

[32]  D. Graham,et al.  Neuroprotective efficacy of ebselen, an anti‐oxidant with anti‐inflammatory actions, in a rodent model of permanent middle cerebral artery occlusion , 1997, British journal of pharmacology.

[33]  I. Izquierdo,et al.  Memory Formation: The Sequence of Biochemical Events in the Hippocampus and Its Connection to Activity in Other Brain Structures , 1997, Neurobiology of Learning and Memory.

[34]  J. Smythies.  Oxidative reactions and schizophrenia: A review-discussion , 1997, Schizophrenia Research.

[35]  S. Stapleton,et al.  Selenium: potent stimulator of tyrosyl phosphorylation and activator of MAP kinase. , 1997, Biochimica et biophysica acta.

[36]  R. Ridley,et al.  The psychology of perseverative and stereotyped behaviour , 1994, Progress in Neurobiology.

[37]  L. Engman,et al.  Expedient synthesis of ebselen and related compounds , 1989 .

[38]  C. Paulmier.  Selenium Reagents and Intermediates in Organic Synthesis , 1986 .

[39]  E. Cadenas,et al.  A novel biologically active seleno-organic compound--I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (Ebselen). , 1984, Biochemical pharmacology.

[40]  R. Burk,et al.  Modification of Chemical Toxicity by Selenium Deficiency , 1983 .

[41]  D. Graham,et al.  Antioxidant ebselen reduces oxidative damage in focal cerebral ischemia. , 2003, Free radical biology & medicine.

[42]  Jeffrey K. Yao,et al.  Oxidative Damage and Schizophrenia , 2001, CNS drugs.

[43]  J. Rocha,et al.  Diphenyl diselenide and diphenyl ditelluride differentially affect δ‐aminolevulinate dehydratase from liver, kidney, and brain of mice , 2000, Journal of biochemical and molecular toxicology.

[44]  K. Takakura,et al.  Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group. , 1998, Stroke.

[45]  P. Moldéus,et al.  Diaryl tellurides as inhibitors of lipid peroxidation in biological and chemical systems. , 1994, Free radical research.

[46]  A. Randrup,et al.  Pharmacology and physiology of stereotyped behavior. , 1974, Journal of psychiatric research.